Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Advocates often highlight the opportunity for meaningful therapeutic outcomes, particularly in diseases where conventional medications have proven limited. However, crucially important to evaluate the substantial financial burden associated with CPI st